Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-01

FDA Approved: VALCHLOR — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Valchlor (mechlorethamine hydrochloride) filed by Helsinn Therapeutics (U.S.), Inc. This action relates to a reg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valchlor (mechlorethamine)

Snippet

SUPPL AP for VALCHLOR (MECHLORETHAMINE HYDROCHLORIDE)